Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

Related Keywords

United States ,American ,Pierre Kyme ,Joyce Allaire ,Brian Varnum ,Armata Pharmaceuticals Inc ,Defense Health Agency ,Innoviva Inc ,Technology Enterprise Consortium ,Prnewswire Armata Pharmaceuticals Inc ,Innoviva Strategic Opportunities ,Us Department Of Defense ,Lifesci Advisors ,Warfighter Medical Research Program ,Recent Developments ,Chief Executive Officer ,Medical Technology Enterprise Consortium ,Joint Warfighter Medical Research ,Armata Pharmaceuticals ,Annual Report ,Sci Advisors ,Consolidated Statements ,Months Ended March ,Nc ,